Authors:
Asou, N
Adachi, K
Tamura, J
Kanamaru, A
Kageyama, S
Hiraoka, A
Omoto, E
Akiyama, H
Tsubaki, K
Saito, K
Kuriyama, K
Oh, H
Kitano, K
Miyawaki, S
Takeyama, K
Yamada, O
Nishikawa, K
Takahashi, M
Matsuda, S
Ohtake, S
Ohno, R
Citation: N. Asou et al., Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group(JALSG), CANC CHEMOT, 48, 2001, pp. S65-S71
Authors:
Hiraoka, A
Ohashi, Y
Okamoto, S
Moriyama, Y
Nagao, T
Kodera, Y
Kanamaru, A
Dohy, H
Masaoka, T
Citation: A. Hiraoka et al., Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation, BONE MAR TR, 28(2), 2001, pp. 181-185
Authors:
Hiraoka, A
Seiki, K
Oda, H
Eguchi, N
Urade, Y
Tominaga, I
Baba, K
Citation: A. Hiraoka et al., Charge microheterogeneity of the beta-trace proteins (lipocalin-type prostaglandin D synthase) in the cerebrospinal fluid of patients with neurological disorders analyzed by capillary isoelectrofocusing, ELECTROPHOR, 22(16), 2001, pp. 3433-3437
Authors:
Hagimoto, R
Koike, K
Sakashita, K
Ishida, T
Nakazawa, Y
Kurokawa, Y
Kamijo, T
Saito, S
Hiraoka, A
Kobayashi, M
Komiyama, A
Citation: R. Hagimoto et al., A possible role for maternal HLA antibody in a case of alloimmune neonatalneutropenia, TRANSFUSION, 41(5), 2001, pp. 615-620
Citation: A. Hiraoka et al., Sodium dodecylsulfate capillary gel electrophoretic measurement of the concentration ratios of albumin and alpha(2)-macroglobulin in cerebrospinal fluid and serum of patients with neurological disorders, J CHROMAT A, 895(1-2), 2000, pp. 339-344
Authors:
Shinjo, K
Takeshita, A
Ohnishi, K
Sakura, T
Miyawaki, S
Hiraoka, A
Takeuchi, M
Tomoyasu, S
Wakita, H
Ata, K
Fukutani, H
Ueda, R
Ohno, R
Citation: K. Shinjo et al., Good prognosis of patients with acute promyelocytic leukemia who achieved second complete remission (CR) with a new retinoid, AM80, after relapse from CR induced by all-trans-retinoic acid, INT J HEMAT, 72(4), 2000, pp. 470-473
Authors:
Karasuno, T
Teshima, H
Hiraoka, A
Nakamura, H
Masaoka, T
Citation: T. Karasuno et al., Successful bone marrow transplantation in an adult patient with reactive hemophagocytic syndrome associated with myelodysplastic syndrome, INT J HEMAT, 71(2), 2000, pp. 180-183
Authors:
Fukuda, H
Teshima, H
Karasuno, T
Hiraoka, A
Nakamura, H
Masaoka, T
Citation: H. Fukuda et al., Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin (vol 71, pg 70, 2000), INT J HEMAT, 71(2), 2000, pp. 192-192
Authors:
Fukuda, H
Teshima, H
Karasuno, T
Hiraoka, A
Nakamura, H
Masaoka, T
Citation: H. Fukuda et al., Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A, INT J HEMAT, 71(1), 2000, pp. 70-74
Authors:
Masaoka, T
Hiraoka, A
Okamoto, S
Kodera, Y
Cao, LX
Lu, DP
Chen, YC
Chen, PM
Kim, DJ
Chiu, E
Liang, R
Teh, A
Citation: T. Masaoka et al., Asian Pacific cooperative study of allogeneic bone marrow transplantation (vol 70, 190, 1999), INT J HEMAT, 71(1), 2000, pp. 90-90
Authors:
Uoshima, N
Karasuno, T
Yagi, T
Kawamoto, S
Hasegawa, T
Yasumi, M
Murakami, M
Teshima, H
Nakamura, H
Hiraoka, A
Masaoka, T
Citation: N. Uoshima et al., Late onset cyclosporine-induced cerebral blindness with abnormal SPECT imagings in a patient undergoing unrelated bone marrow transplantation, BONE MAR TR, 26(1), 2000, pp. 105-108
Authors:
Yagi, T
Karasuno, T
Hasegawa, T
Yasumi, M
Kawamoto, S
Murakami, M
Uosima, N
Nakamura, H
Hiraoka, A
Masaoka, T
Citation: T. Yagi et al., Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir, BONE MAR TR, 25(9), 2000, pp. 1003-1005
Authors:
Nakamura, H
Komatsu, K
Ayaki, M
Kawamoto, S
Murakami, M
Uoshima, N
Yagi, T
Hasegawa, T
Yasumi, M
Karasuno, T
Teshima, H
Hiraoka, A
Masaoka, T
Citation: H. Nakamura et al., Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-best disease after allogeneic bone marrow transplantation, J ALLERG CL, 106(1), 2000, pp. S45-S50
Authors:
Yoshida, M
Tsubaki, K
Kobayashi, T
Tanimoto, M
Kuriyama, K
Murakami, H
Minami, S
Hiraoka, A
Takahashi, I
Naoe, T
Asou, N
Kageyama, S
Tomonaga, M
Saito, H
Ohno, R
Citation: M. Yoshida et al., Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991, INT J HEMAT, 70(4), 1999, pp. 261-267
Authors:
Miyawaki, S
Tanimoto, M
Kobayashi, T
Minami, S
Tamura, J
Omoto, E
Kuriyama, K
Hatake, K
Saito, K
Kanamaru, A
Oh, H
Ohtake, S
Asou, N
Sakamaki, H
Yamada, O
Jinnai, I
Tsubaki, K
Takeyama, K
Hiraoka, A
Matsuda, S
Takahashi, M
Shimazaki, C
Adachi, K
Kageyama, S
Sakura, T
Ohno, R
Citation: S. Miyawaki et al., No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study, INT J HEMAT, 70(2), 1999, pp. 97-104
Authors:
Miyawaki, S
Kobayashi, T
Tanimoto, M
Kuriyama, K
Murakami, H
Yoshida, M
Minami, S
Minato, K
Tsubaki, K
Omoto, E
Oh, H
Jinnai, I
Sakamaki, H
Hiraoka, A
Kanamura, A
Takahashi, I
Saito, K
Naoe, T
Yamada, O
Asou, N
Kageyama, S
Emi, N
Ueda, T
Tomonaga, M
Saito, H
Ueda, R
Ohno, R
Citation: S. Miyawaki et al., Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy, INT J HEMAT, 70(1), 1999, pp. 56-57
Authors:
Kodera, Y
Morishima, Y
Kato, S
Akiyama, Y
Sao, H
Matsuyama, T
Kawa, K
Sakamaki, H
Nakagawa, S
Hirabayashi, N
Dohi, H
Okamoto, S
Hiraoka, A
Gondo, H
Tsuchida, M
O, H
Harada, M
Asano, S
Juji, T
Sasazuki, T
Takaku, F
Citation: Y. Kodera et al., Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia, BONE MAR TR, 24(9), 1999, pp. 995-1003
Authors:
Nakamura, H
Nakao, T
Ujiie, H
Karasuno, T
Teshima, H
Komatsu, K
Ishiguro, S
Hiraoka, A
Masaoka, T
Citation: H. Nakamura et al., Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation, J ALLERG CL, 103(5), 1999, pp. S457-S461
Authors:
Tanimoto, M
Miyawaki, S
Ino, T
Kyo, T
Sakamaki, H
Naoe, T
Hiraoka, A
Asou, N
Ohshima, T
Tsubaki, K
Kuriyama, K
Ueda, T
Minamil, S
Okabe, K
Saito, H
Murakami, H
Hirano, M
Dohy, H
Onozawa, Y
Suzuki, H
Ohno, R
Citation: M. Tanimoto et al., Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG), INT J HEMAT, 68(4), 1998, pp. 421-429
Authors:
Hiraoka, A
Nagasawa, T
Ohta, N
Sugimura, A
Shimizu, N
Ooi, K
Shimizu, S
Citation: A. Hiraoka et al., A human myeloid cell line producing stem cell growth factor, KPB-M15, secretes another growth factor active on murine hematopoietic progenitor cells, ACT HAEMAT, 100(4), 1998, pp. 174-180